Notify me when Alex Keun Mo Yang files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Polaryx Therapeutics, Inc. | Common stock, par value $0.0001 per share ("Common Stock") | 48% | 22,744,796 | Alex Keun Mo Yang | 29 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|